Search Count: 6
 |
Crystal Structures Of Diastereomer (R,S,S)-13B (13B-H) In Complex With The Sars-Cov-2 Mpro.
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.75 Å Release Date: 2022-10-12 Classification: ANTIVIRAL PROTEIN Ligands: V9R, DMS, CL |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2022-10-12
Ligands: V9R, DMS, CL
 |
Crystal Structures Of Diastereomer (S,S,S)-13B (13B-K) In Complex With The Sars-Cov-2 Mpro
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2022-10-12 Classification: ANTIVIRAL PROTEIN Ligands: O6K, CL |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2022-10-12
Ligands: O6K, CL
 |
Crystal Structure Of The Complex Resulting From The Reaction Between The Sars-Cov Main Protease And Tert-Butyl (1-((S)-3-Cyclohexyl-1-(((S)-4-(Cyclopropylamino)-3,4-Dioxo-1-((S)-2-Oxopyrrolidin-3-Yl)Butan-2-Yl)Amino)-1-Oxopropan-2-Yl)-2-Oxo-1,2-Dihydropyridin-3-Yl)Carbamate
Organism: Severe acute respiratory syndrome coronavirus
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2020-03-18 Classification: VIRAL PROTEIN Ligands: OEW, DMS |
Organism: Severe acute respiratory syndrome coronavirus
Method: X-RAY DIFFRACTION
Release Date: 2020-03-18
Ligands: OEW, DMS
 |
Crystal Structure Of The Free Enzyme Of The Sars-Cov-2 (2019-Ncov) Main Protease
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.75 Å Release Date: 2020-03-04 Classification: VIRAL PROTEIN |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2020-03-04
 |
Crystal Structure (Monoclinic Form) Of The Complex Resulting From The Reaction Between Sars-Cov-2 (2019-Ncov) Main Protease And Tert-Butyl (1-((S)-1-(((S)-4-(Benzylamino)-3,4-Dioxo-1-((S)-2-Oxopyrrolidin-3-Yl)Butan-2-Yl)Amino)-3-Cyclopropyl-1-Oxopropan-2-Yl)-2-Oxo-1,2-Dihydropyridin-3-Yl)Carbamate (Alpha-Ketoamide 13B)
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2020-03-04 Classification: VIRAL PROTEIN Ligands: DMS, O6K |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2020-03-04
Ligands: DMS, O6K
 |
Crystal Structure (Orthorhombic Form) Of The Complex Resulting From The Reaction Between Sars-Cov-2 (2019-Ncov) Main Protease And Tert-Butyl (1-((S)-1-(((S)-4-(Benzylamino)-3,4-Dioxo-1-((S)-2-Oxopyrrolidin-3-Yl)Butan-2-Yl)Amino)-3-Cyclopropyl-1-Oxopropan-2-Yl)-2-Oxo-1,2-Dihydropyridin-3-Yl)Carbamate (Alpha-Ketoamide 13B)
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2020-03-04 Classification: VIRAL PROTEIN Ligands: O6K |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2020-03-04
Ligands: O6K